In the title compound, C 17 H 14 ClFO 2 S, the dihedral angle between the mean planes of the benzofuran ring system [maximum deviation = 0.037 (2) 
For the pharmacological properties of benzofuran compounds, see: Aslam et al. (2009) ; Galal et al. (2009) ; Howlett et al. (1999) ; Khan et al. (2005) ; Ono et al. (2002) . For natural products with a benzofuran ring, see: Akgul & Anil (2003) ; Soekamto et al. (2003) . For the synthesis of the starting material 5-chloro-3-(4-fluorophenylsulfanyl)-2,4,6-trimethyl-1-benzofuran, see: Choi et al. (1999) . For a related structure, see: Choi et al. (2012) . Table 1 Hydrogen-bond geometry (Å , ). Benzofuran compounds show interesting biological activity such as antibacterial and antifungal, antitumor and antiviral, antimicrobial activities (Aslam et al. 2009 , Galal et al., 2009 , Khan et al., 2005 , and potential inhibitor of β-amyloid aggregation (Howlett et al., 1999 , Ono et al., 2002 . These benzofuran compounds occur in a great number of natural products. (Akgul & Anil, 2003 , Soekamto et al., 2003 . As a part of our ongoing study of 3-arylsulfinyl-5-chloro-2-methyl-1-benzofuran derivatives containing 4-bromophenylsulfinyl substituent in 3-position (Choi et al., 2012) , we report herein on the crystal structure of the title compound.
In the title molecule ( (Table 1) , resulting in a three-dimensional network.
S2. Experimental
The starting material 5-chloro-3-(4-fluorophenylsulfanyl)-2,4,6-trimethyl-1-benzofuran was prepared by literature method (Choi et al. 1999) . 3-Chloroperoxybenzoic acid (77%, 224 mg, 1.0 mmol) was added in small portions to a stirred solution of 5-chloro-3-(4-fluorophenylsulfanyl)-2,4,6-trimethyl-1-benzofuran (288 mg, 0.9 mmol) in dichloromethane (20 mL) at 273 K. After being stirred at room temperature for 10h, the mixture was washed with saturated sodium bicarbonate solution (2 X 10 mL) and the organic layer was separated, dried over magnesium sulfate, filtered and concentrated at reduced pressure. The residue was purified by column chromatography (hexane-ethyl acetate, 2:1 v/v) to afford the title compound as a colorless solid [yield 64% (215 mg); m.p. 432-433 K; R f = 0.62 (hexane-ethyl acetate, 2:1
Single crystals suitable for X-ray diffraction were prepared by slow evaporation of a solution of the title compound (24 mg) in ethyl acetate (15 mL) at room temperature.
S3. Refinement
All H atoms were positioned geometrically and refined using a riding model, with C-H = 0.95 Å for aryl and 0.98 Å for methyl H atoms, U iso (H) = 1.2U eq (C) for aryl and 1.5U eq (C) for methyl H atoms. The positions of methyl hydrogens were optimized using the SHELXL-97 command AFIX 137 (Sheldrick, 2008 
Figure 1
The molecular structure of the title compound with the atom numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are presented as small spheres of arbitrary radius. Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
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